The Heterogeneity of Cancer Metabolism

Genetic alterations in cancer, in addition to being the fundamental drivers of tumorigenesis, can give rise to a variety of metabolic adaptations that allow cancer cells to survive and proliferate in diverse tumor microenvironments. This metabolic flexibility is different from normal cellular metabo...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Le, Anne (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Σειρά:Advances in Experimental Medicine and Biology, 1063
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03475nam a2200481 4500
001 978-3-319-77736-8
003 DE-He213
005 20191220125552.0
007 cr nn 008mamaa
008 180626s2018 gw | s |||| 0|eng d
020 |a 9783319777368  |9 978-3-319-77736-8 
024 7 |a 10.1007/978-3-319-77736-8  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 4 |a The Heterogeneity of Cancer Metabolism  |h [electronic resource] /  |c edited by Anne Le. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a XV, 183 p. 31 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 1063 
505 0 |a Part 1: The metabolism of cancer cells -- Chapter 1: Glucose Metabolism -- Chapter 2: Glutamine Metabolism -- Chapter 3: Amino Acid Metabolism -- Chapter 4: Lipid Metabolism -- Chapter 5: Epigenetics and oncometabolites -- Part 2: Heterogeneity of Cancer Metabolism - Chapter 1: Specific oncogenetic mutations lead to specific metabolic phenotypes within the same tissue of origin -- Chapter 2: Intratumoral heterogeneity of cancer cell metabolism -- - Chapter 3: Differential metabolism in vitro and in vivo -- Part 3: Carcinoma associated fibroblasts -- Chapter 1: Characteristics of CAF's -- Chapter 2: Reverse Warbug EFF -- Chapter 3: Metabolic exchange between CAFs and cancer cells. . 
520 |a Genetic alterations in cancer, in addition to being the fundamental drivers of tumorigenesis, can give rise to a variety of metabolic adaptations that allow cancer cells to survive and proliferate in diverse tumor microenvironments. This metabolic flexibility is different from normal cellular metabolic processes and leads to heterogeneity in cancer metabolism within the same cancer type or even within the same tumor. In this book, we delve into the complexity and diversity of cancer metabolism, and highlight how understanding the heterogeneity of cancer metabolism is fundamental to the development of effective metabolism-based therapeutic strategies. Deciphering how cancer cells utilize various nutrient resources will enable clinicians and researchers to pair specific chemotherapeutic agents with patients who are most likely to respond with positive outcomes, allowing for more cost-effective and personalized cancer therapeutic strategies. 
650 0 |a Cancer research. 
650 0 |a Immunology. 
650 1 4 |a Cancer Research.  |0 http://scigraph.springernature.com/things/product-market-codes/B11001 
650 2 4 |a Immunology.  |0 http://scigraph.springernature.com/things/product-market-codes/B14000 
700 1 |a Le, Anne.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319777351 
776 0 8 |i Printed edition:  |z 9783319777375 
776 0 8 |i Printed edition:  |z 9783030085254 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 1063 
856 4 0 |u https://doi.org/10.1007/978-3-319-77736-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)